Monitoring the HeMAtological TOXicity of Drugs (HeMATOX)

Clinical trial NCT03828942 · COMPLETED

Trial details

NCT number: NCT03828942
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: COMPLETED
Study type: OBSERVATIONAL

Hematological Abnormality Hematotoxicity

Start date: 2019-02-01
Primary completion: 2022-02-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.